Radiolabeled high affinity peptidomimetic antagonist selectively targets αvβ3 receptor-positive tumor in mice
- 1 May 2007
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 34 (4) , 363-370
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Synthesis and biological evaluation of a 99mTc-labelled cyclic RGD peptide for imaging the αvβ3 expressionNuklearmedizin-Nuclear Medicine, 2004
- MicroPET and Autoradiographic Imaging of Breast Cancer αv-Integrin Expression Using 18F- and 64Cu-Labeled RGD PeptideBioconjugate Chemistry, 2003
- Design, Synthesis, and Evaluation of Radiolabeled Integrin α
v
β 3 Receptor Antagonists for Tumor Imaging and RadiotherapyCancer Biotherapy and Radiopharmaceuticals, 2003
- Integrin activation and structural rearrangementImmunological Reviews, 2002
- Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapyInternational Journal of Cancer, 2000
- Neovascular Targeting with Cyclic RGD Peptide (cRGDf-ACHA) to Enhance Delivery of RadioimmunotherapyCancer Biotherapy and Radiopharmaceuticals, 2000
- αv Integrins as receptors for tumor targeting by circulating ligandsNature Biotechnology, 1997
- Integrins, angiogenesis and vascular cell survivalChemistry & Biology, 1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Arg-Gly-Asp: A versatile cell recognition signalCell, 1986